Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3
Proceedings of the National Academy of Sciences · 09.05.2023 · 120 (19)
DOI: 10.1073/pnas.2212118120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023-05. Verfasst von Cristine J Reitz und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1M8. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Heart Failure. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Gouvernement du Canada | Canadian Institutes of Health Research, Translational Biology and Engineering Program.
Abstract (Originalsprache)
The prognosis and treatment outcomes of heart failure (HF) patients rely heavily on disease etiology, yet the majority of underlying signaling mechanisms are complex and not fully elucidated. Phosphorylation is a major point of protein regulation with rapid and profound effects on the function and activity of protein networks. Currently, there is a lack of comprehensive proteomic and phosphoproteomic studies examining cardiac tissue from HF patients with either dilated dilated cardiomyopathy (DCM) or ischemic cardiomyopathy (ICM). Here, we used a combined proteomic and phosphoproteomic approach to identify and quantify more than 5,000 total proteins with greater than 13,000 corresponding phosphorylation sites across explanted left ventricle (LV) tissue samples, including HF patients with DCM vs. nonfailing controls (NFC), and left ventricular infarct vs. noninfarct, and periinfarct vs. noninfarct regions of HF patients with ICM. Each pair-wise comparison revealed unique global proteomic and phosphoproteomic profiles with both shared and etiology-specific perturbations. With this approach, we identified a DCM-associated hyperphosphorylation cluster in the cardiomyocyte intercalated disc (ICD) protein, αT-catenin (CTNNA3). We demonstrate using both ex vivo isolated cardiomyocytes and in vivo using an AAV9-mediated overexpression mouse model, that CTNNA3 phosphorylation at these residues plays a key role in maintaining protein localization at the cardiomyocyte ICD to regulate conductance and cell–cell adhesion. Collectively, this integrative proteomic/phosphoproteomic approach identifies region- and etiology-associated signaling pathways in human HF and describes a role for CTNNA3 phosphorylation in the pathophysiology of DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1M8.
- Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Toronto, ON M5G 1M1.
- Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3.
- Department of Biology, York University, Toronto, ON M3J 1P3.
- Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118.
- Department of Biology, Boston University School of Medicine, Boston, MA 02118.
ORCID-Profile: Cristine J Reitz, Gavin Y Oudit, Uros Kuzmanov, Anthony O Gramolini
Förderung
- CIHR
- Gouvernement du Canada | Canadian Institutes of Health Research
- Translational Biology and Engineering Program
- Ted Rogers Centre
Zitieren
APA
Reitz, C. J., Tavassoli, M., Kim, D. H., Shah, S., Lakin, R., Teng, A. C. T., Zhou, Y. Q., Li, W., Hadipour-Lakmehsari, S., Backx, P. H., Emili, A., Oudit, G. Y., Kuzmanov, U., & Gramolini, A. O. (2023). Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3. Proceedings of the National Academy of Sciences, 120(19). https://doi.org/10.1073/pnas.2212118120
Vancouver
Reitz CJ, Tavassoli M, Kim DH, Shah S, Lakin R, Teng ACT, et al. Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3. Proceedings of the National Academy of Sciences. 2023;120(19). doi:10.1073/pnas.2212118120
BibTeX
@article{Reitz2023,
author = {Reitz, Cristine J and Tavassoli, Marjan and Kim, Da Hye and Shah, Saumya and Lakin, Robert and Teng, Allen C T and Zhou, Yu-Qing and Li, Wenping and Hadipour-Lakmehsari, Sina and Backx, Peter H and Emili, Andrew and Oudit, Gavin Y and Kuzmanov, Uros and Gramolini, Anthony O},
title = {Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {19},
doi = {10.1073/pnas.2212118120}
}
EUVIMED